Search research articles
Contact Us
Filters
Showing results (611-620 of 629) with videos related to
Page
of 63
Sort By:
Nature
|
March 4, 2015
Erratum: A new antibiotic kills pathogens without detectable resistance
Losee L Ling, Tanja Schneider, Aaron J Peoples, et al.
Nature
|
January 7, 2015
A new antibiotic kills pathogens without detectable resistance
Losee L Ling, Tanja Schneider, Aaron J Peoples, et al.
JCI Insight
|
August 12, 2024
Enhancing radiotherapy response via intratumoral injection of a TLR9 agonist in autochthonous murine sarcomas
Chang Su, Collin L Kent, Matthew Pierpoint, et al.
Biorxiv : the Preprint Server for Biology
|
January 23, 2024
Enhancing radiotherapy response via intratumoral injection of the TLR9 agonist CpG to stimulate CD8 T cells in an autochthonous mouse model of sarcoma
Chang Su, Collin L Kent, Matthew Pierpoint, et al.
Molecular Cancer Therapeutics
|
October 13, 2022
Ubiquitinated PCNA Drives USP1 Synthetic Lethality in Cancer
Antoine Simoneau, Justin L Engel, Madhavi Bandi, et al.
Molecular Cancer Research : MCR
|
March 14, 2019
E-Cadherin Represses Anchorage-Independent Growth in Sarcomas through Both Signaling and Mechanical Mechanisms
Mohit Kumar Jolly, Kathryn E Ware, Shengnan Xu, et al.
Journal of Medicinal Chemistry
|
January 12, 2017
Discovery of Potent Cyclophilin Inhibitors Based on the Structural Simplification of Sanglifehrin A
Victoria A Steadman, Simon B Pettit, Karine G Poullennec, et al.
Journal of Medicinal Chemistry
|
February 11, 2016
Discovery of 6-Amino-2-{[(1S)-1-methylbutyl]oxy}-9-[5-(1-piperidinyl)pentyl]-7,9-dihydro-8H-purin-8-one (GSK2245035), a Highly Potent and Selective Intranasal Toll-Like Receptor 7 Agonist for the Treatment of Asthma
Keith Biggadike, Mahbub Ahmed, Doug I Ball, et al.
Cancer Cell
|
April 13, 2011
Conformational control inhibition of the BCR-ABL1 tyrosine kinase, including the gatekeeper T315I mutant, by the switch-control inhibitor DCC-2036
Wayne W Chan, Scott C Wise, Michael D Kaufman, et al.
Science Translational Medicine
|
January 8, 2016
A mouse-human phase 1 co-clinical trial of a protease-activated fluorescent probe for imaging cancer
Melodi Javid Whitley, Diana M Cardona, Alexander L Lazarides, et al.
Page
of 63
Search research articles
Search
Showing results (611-620 of 629) with videos related to
Sort By:
Page
of 63
Nature
|
March 4, 2015
Erratum: A new antibiotic kills pathogens without detectable resistance
Losee L Ling, Tanja Schneider, Aaron J Peoples, et al.
Nature
|
January 7, 2015
A new antibiotic kills pathogens without detectable resistance
Losee L Ling, Tanja Schneider, Aaron J Peoples, et al.
JCI Insight
|
August 12, 2024
Enhancing radiotherapy response via intratumoral injection of a TLR9 agonist in autochthonous murine sarcomas
Chang Su, Collin L Kent, Matthew Pierpoint, et al.
Biorxiv : the Preprint Server for Biology
|
January 23, 2024
Enhancing radiotherapy response via intratumoral injection of the TLR9 agonist CpG to stimulate CD8 T cells in an autochthonous mouse model of sarcoma
Chang Su, Collin L Kent, Matthew Pierpoint, et al.
Molecular Cancer Therapeutics
|
October 13, 2022
Ubiquitinated PCNA Drives USP1 Synthetic Lethality in Cancer
Antoine Simoneau, Justin L Engel, Madhavi Bandi, et al.
Molecular Cancer Research : MCR
|
March 14, 2019
E-Cadherin Represses Anchorage-Independent Growth in Sarcomas through Both Signaling and Mechanical Mechanisms
Mohit Kumar Jolly, Kathryn E Ware, Shengnan Xu, et al.
Journal of Medicinal Chemistry
|
January 12, 2017
Discovery of Potent Cyclophilin Inhibitors Based on the Structural Simplification of Sanglifehrin A
Victoria A Steadman, Simon B Pettit, Karine G Poullennec, et al.
Journal of Medicinal Chemistry
|
February 11, 2016
Discovery of 6-Amino-2-{[(1S)-1-methylbutyl]oxy}-9-[5-(1-piperidinyl)pentyl]-7,9-dihydro-8H-purin-8-one (GSK2245035), a Highly Potent and Selective Intranasal Toll-Like Receptor 7 Agonist for the Treatment of Asthma
Keith Biggadike, Mahbub Ahmed, Doug I Ball, et al.
Cancer Cell
|
April 13, 2011
Conformational control inhibition of the BCR-ABL1 tyrosine kinase, including the gatekeeper T315I mutant, by the switch-control inhibitor DCC-2036
Wayne W Chan, Scott C Wise, Michael D Kaufman, et al.
Science Translational Medicine
|
January 8, 2016
A mouse-human phase 1 co-clinical trial of a protease-activated fluorescent probe for imaging cancer
Melodi Javid Whitley, Diana M Cardona, Alexander L Lazarides, et al.
Page
of 63